Warning letter
NuVasive Inc: warning letter of Mar 12, 2013
FDA warning letter 392911 · Los Angeles District Office
Key facts
| Reference number | 392911 |
|---|---|
| Company | NuVasive Inc |
| Subject | Premarket Approval/Misbranded/Adulterated |
| Issue date | Mar 12, 2013 |
| Posted date | Mar 12, 2013 |
| Issuing office | Los Angeles District Office |
| Product type | Devices |
| CFR sections cited | 807.81(a)(3)(ii), 807.81(b) |
| Inspection city | San Diego |
| Inspection ZIP | 92121 |
| Inspection start date | Oct 29, 2012 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: